DIGESTIVE DISEASES AND SCIENCES, a renowned journal published by Springer, plays a pivotal role in advancing the fields of gastroenterology and physiology. With a rich publication history spanning from 1979 to 2024, this journal not only holds an impressive Q1 ranking in both categories but also ranks 34th out of 167 in Gastroenterology and 60th out of 193 in Physiology according to Scopus, reflecting its significant impact and reputation within the academic community. Despite being a traditional journal without open access options, it remains a crucial platform for researchers, professionals, and students seeking to disseminate their findings and stay abreast of the latest developments in digestive health. The journal is accessible to a global audience and is dedicated to publishing high-quality, peer-reviewed research, making it an invaluable resource for anyone involved in the study or treatment of digestive diseases.

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

Surgical Oncology-Oxford is a prestigious academic journal published by Elsevier Science Ltd, dedicated to advancing the field of surgical oncology. Since its establishment in 1992, the journal has provided a vital platform for disseminating cutting-edge research, clinical advancements, and innovative surgical techniques. With a focus on both surgery and oncology, the journal is ranked in the Q2 category in Surgery and Q3 in Oncology for 2023, reflecting its commitment to quality and impactful contributions. It ranks #107 out of 551 in Medicine_Surgery and #184 out of 404 in Medicine_Oncology as per Scopus metrics, illustrating its significant role in the academic landscape. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that only the highest quality research is published. By examining the latest surgical methodologies and oncological insights, Surgical Oncology-Oxford plays a crucial role in enhancing clinical practice and improving patient outcomes, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of the field.

GASTROINTESTINAL ENDOSCOPY, published by MOSBY-ELSEVIER, stands as a leading journal in the fields of gastroenterology and radiology, boasting an impressive impact factor that reflects its esteemed position within the academic community. Established in 1965 and set to continue through 2024, this journal is critical for disseminating high-quality research that informs clinical practice and enhances patient care. With a robust Scopus ranking — 25th out of 333 in Radiology, Nuclear Medicine and Imaging, and 15th out of 167 in Gastroenterology — it proudly maintains a #1 quartile status in both disciplines as of 2023. While the journal does not offer open access, it remains invaluable for researchers, professionals, and students seeking to stay ahead in the rapidly evolving fields of gastrointestinal pathology and innovative endoscopic procedures. Its comprehensive scope encompasses technological advancements, clinical studies, and critical reviews, making it a vital resource for advancing knowledge and supporting professional development.

Clinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.

The GE Portuguese Journal of Gastroenterology, published by KARGER, is a prominent platform in the field of gastroenterology, providing a vital forum for the dissemination of high-quality research since its establishment. With an open access model implemented in 2012, the journal ensures that emerging findings in gastrointestinal health are readily accessible to a global audience, facilitating the exchange of critical knowledge among researchers, practitioners, and students alike. Based in Switzerland, this journal has earned a respected position within the academic community, currently holding a Q3 ranking in the gastroenterology category for 2023, alongside a Scopus rank of #113 out of 167 in its field. Spanning converged years from 2014 to 2024, the GE Portuguese Journal of Gastroenterology aims to bridge gaps in research and practice, fostering collaboration and innovation across diverse areas within the discipline. Authors and readers alike benefit from the journal's commitment to advancing knowledge and practice in gastroenterology.

Gastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.

COLOPROCTOLOGY is a specialized journal published by Springer, dedicated to advancing knowledge and understanding in the fields of Gastroenterology and Surgery. With an ISSN of 0174-2442 and an E-ISSN of 1615-6730, this journal holds a prominent position in the medical literature, despite being categorized in the Q4 quartile as per the latest metrics for both disciplines. The convergence of research published from 1998 to 2024 reflects the journal's long-standing commitment to addressing critical issues in coloproctology, offering insights into clinical practices, surgical techniques, and gastrointestinal disorders. While the journal does not currently provide open access options, it remains a vital resource for professionals, researchers, and students aiming to enhance their understanding of complex gastrointestinal health challenges. With its esteemed publisher, Springer, COLOPROCTOLOGY aims to foster innovation and scholarly dialogue within the medical community.

DISEASES OF THE ESOPHAGUS is a prestigious, peer-reviewed journal published by Oxford University Press Inc, focusing on the clinical and translational aspects of esophageal diseases. With an ISSN of 1120-8694 and an E-ISSN of 1442-2050, this journal has cultivated a reputation for excellence since its inception in 1988. Its impact is underscored by its prestigious Q1 ranking in both Gastroenterology and Medicine (miscellaneous) categories as of 2023, positioning it among the top tier of journals within these fields. The journal's scholarly contributions span a wide range of topics relevant to researchers, healthcare professionals, and clinical practitioners, emphasizing advancement in diagnosis and treatment of esophageal conditions. Although currently not an open-access journal, its content is widely accessible through institutional libraries, ensuring that valuable research reaches the hands of those dedicated to enhancing patient care. As it continues publishing through 2024, DISEASES OF THE ESOPHAGUS remains an essential resource for those engaged in understanding and managing esophageal health.

Colorectal Cancer is an esteemed academic journal published by Taylor & Francis Ltd, focusing on all aspects of colorectal cancer research, diagnosis, treatment, and prevention. With an ISSN of 1758-194X and an E-ISSN of 1758-1958, this journal serves as a critical platform for publishing innovative studies, clinical trials, and meta-analyses to advance the understanding of colorectal cancer. Though not yet categorized under open access, it provides valuable insights and is committed to enhancing the visibility of research contributions within the field. The journal aims to foster collaboration and communication among researchers, clinicians, and students dedicated to improving patient outcomes and exploring novel therapeutic strategies. With its rigorous editorial standards, Colorectal Cancer plays a pivotal role in shaping future research and clinical practices, making it indispensable for professionals in oncology, gastroenterology, and related fields.